Welcome to Advances in Clinical and Experimental Medicine, an esteemed publication by WROCLAW MEDICAL UNIVERSITY, dedicated to advancing the essential fields of clinical and experimental medicine. With an open access model since 2017, this journal ensures that researchers, healthcare professionals, and students worldwide can freely access high-quality scientific content. Covering a broad spectrum of topics including biochemistry, genetics, internal medicine, and pharmacology, Advances in Clinical and Experimental Medicine has established itself as a pivotal resource in the scientific community, currently holding prestigious rankings such as Q2 in Biochemistry, Genetics, and Molecular Biology (miscellaneous) and Q1 in Reviews and References (medical) for 2023. Spanning over two decades of rigorous research publication, the journal is a critical platform for sharing innovative findings and fostering collaboration among scholars, making it an invaluable asset for those at the forefront of medical science.

EXPERIMENTAL BIOLOGY AND MEDICINE is a distinguished open-access journal published by FRONTIERS MEDIA SA, specializing in the interdisciplinary fields of biochemistry, genetics, and medicine. With an ISSN of 1535-3702 and an E-ISSN of 1535-3699, this journal presents a robust platform for cutting-edge research and innovative clinical studies. Since its inception in 1996, it has evolved to feature a broad scope that caters to the evolving needs of researchers, professionals, and students, ensuring a dynamic dissemination of knowledge in biological and medical sciences. In 2023, the journal achieved a notable Q2 ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories, reflecting its strong impact and relevance within the academic community, as supported by its Scopus rank of #59 out of 221 in general biochemistry and genetics, placing it in the 73rd percentile. By offering open access options, EXPERIMENTAL BIOLOGY AND MEDICINE aims to maximize the reach and visibility of research findings, fostering collaboration and knowledge sharing across global audiences. Researchers are encouraged to contribute to this vital resource as it continues to advance the understanding of biological mechanisms and therapeutic approaches crucial for modern medicine.

YONSEI MEDICAL JOURNAL, published by the Yonsei University College of Medicine, stands as a premier open-access journal in the field of medicine since its inception. With an ISSN of 0513-5796 and an E-ISSN of 1976-2437, this esteemed journal has been diligently serving the scientific community since 1963, featuring crucial research developments that span multiple aspects of medical science. Hailing from South Korea and ranked in the Q2 category for Medicine (miscellaneous) in the 2023 Scopus rankings, it holds an impressive rank of #115 out of 636 in General Medicine, placing it in the 81st percentile. The journal is dedicated to facilitating the dissemination of knowledge through its open-access platform, which has been pivotal in enhancing visibility and accessibility for researchers, professionals, and students worldwide. As it continues to publish cutting-edge findings, YONSEI MEDICAL JOURNAL not only contributes to ongoing medical education but also fosters groundbreaking research that shapes the future of healthcare.

Current Medical Science is a prominent academic journal dedicated to advancing knowledge in the fields of Medicine, Biochemistry, and Genetics. Published by SPRINGER with an ISSN of 2096-5230 and E-ISSN 2523-899X, this journal is based in China and serves as a vital resource for researchers, professionals, and students alike. With a focus on innovative research and emerging trends, Current Medical Science has established itself with an impactful presence, operating under Open Access guidelines to ensure wide dissemination of scientific findings. The journal's recognition is underscored by its impressive Scopus rankings, including a Q3 quartile placement in Biochemistry and Genetics as of 2023. It is noteworthy that the journal spans converged years from 2018 to 2024, providing a comprehensive platform for scholarly discussions and developments that drive the evolution of medical science. As it continues to publish influential research, Current Medical Science plays an essential role in bridging the gap between laboratory science and clinical application.

Acta Oto-Laryngologica Case Reports, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to the dissemination of high-quality case reports in the field of otolaryngology. Since its inception in 2016, this journal has been a vital platform for researchers and clinicians to share unique clinical insights and advancements related to ear, nose, and throat disorders. With an ISSN of 2377-2484, it provides unparalleled access to the latest findings, facilitating collaboration and innovation among professionals in otolaryngology. The journal's commitment to open-access publishing ensures that critical research is freely available to a global audience, enhancing the visibility and impact of its contributors' work. Researchers, practitioners, and students in the medical field will find valuable resources and case studies that not only contribute to professional development but also address current challenges in patient care.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, published by SAGE Publications Ltd, serves as a vital platform in the fields of biochemistry and medicine, showcasing significant research contributions since its inception in 1972. With an Open Access policy implemented in 2012, this journal promotes unrestricted dissemination of knowledge, catering to a global audience and ensuring that critical findings are accessible to researchers, healthcare professionals, and students alike. With an impressive scope spanning diverse biomedical disciplines, the journal ranks in the Q3 quartile for both biochemistry and medicine, affirming its relevance and impact within these evolving fields. Hailing from the United Kingdom, the journal is dedicated to fostering a rich academic dialogue that bridges laboratory discoveries and clinical applications, making it an essential resource for those engaged in international medical research. Its ongoing commitment to excellence is reflected in its convergence until 2024, inviting high-quality submissions that contribute to advancements in medical science.

Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.

ACTA CHIRURGICA BELGICA is a prestigious journal published by Taylor & Francis Ltd that has been in circulation since 1946, contributing significantly to the fields of Medicine and Surgery. With its ISSN 0001-5458 and E-ISSN 2577-0160, this journal offers a rich resource for researchers, clinicians, and students seeking to expand their knowledge and stay updated on the latest advancements in surgical practices. Operating under the category quartiles Q3 for both Medicine (miscellaneous) and Surgery as of 2023, it ranks at a commendable position among the 551 entries in Scopus’ Surgery category, reflecting its relevance and competitiveness in the academic landscape. While the journal follows a subscription model, it remains a vital platform for disseminating high-quality research findings, case studies, and reviews that address contemporary challenges in surgery and related medical fields. As it converges towards its landmark 2024 publication, ACTA CHIRURGICA BELGICA continues to uphold its mission to enhance knowledge and foster collaboration within the surgical community.

Journal of Clinical Medicine Research-Canada is a prestigious and dynamic platform dedicated to the dissemination of novel research in the field of medicine. Published by ELMER PRESS INC, the journal has gained a significant reputation since its inception, achieving an impressive Q2 ranking in the Medicine (miscellaneous) category and placing within the 85th percentile of general medicine rankings in Scopus. This indicates its notable contribution and relevance within the medical community. As an active participant in global healthcare discussions, the journal covers a wide spectrum of topics, ranging from clinical practices to innovative therapeutic interventions. With its commitment to delivering high-quality, peer-reviewed content, the Journal of Clinical Medicine Research-Canada serves as an invaluable resource for researchers, professionals, and students looking to stay at the forefront of medical advancements. Though currently not an Open Access journal, it remains a critical publication for those seeking to deepen their understanding and engage with cutting-edge research in the field. The journal is headquartered in Ontario, Canada, and encourages submissions that push the boundaries of clinical medicine, thereby fostering an environment of scholarly excellence.

JOURNAL OF INVESTIGATIVE MEDICINE, published by SAGE PUBLICATIONS LTD, serves as a vital resource for researchers and professionals in the fields of biochemistry, genetics, and medicine. With an impressive Scopus ranking placing it in the 64th percentile, the journal consistently showcases significant research, fostering advancements in our understanding of complex biological processes. Spanning from 1994 to 2024, this quarterly publication is recognized as Q2 in both Biochemistry, Genetics and Molecular Biology and Medicine categories, indicating its relevance and quality in these disciplines. While the journal does not offer open access, it provides robust insights that assist in shaping current academic and clinical practices. Located in the United States, the JOURNAL OF INVESTIGATIVE MEDICINE is essential for scholars aiming to stay at the forefront of investigative medical research.